Insider Profile
Martin, Helen
1
Companies Filed At
5
Open-Market Buys (2yr)
$99K
Buy Value (2yr, open-market)
Apr 07, 2026
Most Recent Trade
23
Credibility
Score
32%
Hit Rate
+7.7%
Avg 90d Return
-3.1%
Median 90d Return
22
Evaluated Trades
+97.6%
Best Trade
-24.7%
Worst Trade
Hit rate and returns are based on 22 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.
Cross-Company Track Record
17%
Hit Rate · 90d
-14.0%
Median Alpha · 90d
6
Closed Buys Evaluated
17%
Beat XIU
All-insider base rate: 59% hit rate  · +1.3% mean alpha (n=11504)
cluster buyer high frequency size concentrated
Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later. Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.
Research 6 closed buys with individual return outcomes available on the Research plan.
Date Company Role Nature Dir. Shares Price Value Score
Apr 07, 2026 $OGI
Organigram Holdings
— Comp. Grant Buy 50,000 — — 10
Dec 19, 2025 $OGI
Organigram Holdings
— Exercise Buy 6,292 — — 10
Dec 19, 2025 $OGI
Organigram Holdings
— Open Market Buy 3,584 $2.92 $10K 10
Dec 19, 2025 $OGI
Organigram Holdings
— Exercise Sell 6,292 — — 10
Dec 19, 2025 $OGI
Organigram Holdings
— Comp. Grant Buy 51,778 — — 10
Oct 30, 2025 $OGI
Organigram Holdings
— Exercise Buy 16,027 — — 10
Oct 30, 2025 $OGI
Organigram Holdings
— Open Market Buy 9,152 $2.25 $21K 10
Oct 30, 2025 $OGI
Organigram Holdings
— Exercise Sell 16,027 — — 10
Oct 28, 2025 $OGI
Organigram Holdings
— Comp. Grant Buy 51,778 $2.44 $126K 10
Oct 28, 2025 $OGI
Organigram Holdings
— Comp. Grant Buy 51,778 $2.44 $126K 10
Oct 21, 2025 $OGI
Organigram Holdings
— Exercise Buy 22,519 — — 10
Oct 21, 2025 $OGI
Organigram Holdings
— Open Market Buy 12,848 $2.49 $32K 10
Oct 21, 2025 $OGI
Organigram Holdings
— Exercise Sell 22,519 — — 10
Sep 09, 2025 $OGI
Organigram Holdings
— Exercise Buy 11,651 — — 10
Sep 09, 2025 $OGI
Organigram Holdings
— Open Market Buy 6,654 $2.25 $15K 10
Sep 09, 2025 $OGI
Organigram Holdings
— Exercise Sell 11,651 — — 10
Aug 01, 2025 $OGI
Organigram Holdings
— Exercise Sell 19,333 — — 10
Aug 01, 2025 $OGI
Organigram Holdings
— Exercise Buy 19,333 — — 10
Aug 01, 2025 $OGI
Organigram Holdings
— Open Market Buy 11,014 $1.86 $20K 10
Oct 28, 2024 $OGI
Organigram Holdings
— Comp. Grant Buy 48,081 $2.54 $122K 10
Oct 28, 2024 $OGI
Organigram Holdings
— Comp. Grant Buy 48,081 $2.54 $122K 10
Aug 16, 2024 $OGI
Organigram Holdings
— Open Market Buy 11,027 $2.76 $30K 10
Aug 16, 2024 $OGI
Organigram Holdings
— Exercise Sell 19,334 — — 10
Aug 16, 2024 $OGI
Organigram Holdings
— Exercise Buy 19,334 $2.76 $53K 10
Feb 27, 2024 $OGI
Organigram Holdings
— Comp. Grant Buy 58,000 $2.73 $158K 10
Dec 21, 2023 $OGI
Organigram Holdings
— Comp. Grant Buy 81,590 $1.75 $143K 10
Dec 21, 2023 $OGI
Organigram Holdings
— Comp. Grant Buy 67,557 $1.75 $118K 10
Jul 05, 2023 $OGI
Organigram Holdings
— Corp. Event Sell 54,073 — — 10
Jul 05, 2023 $OGI
Organigram Holdings
— Corp. Event Sell 6,061 — — 10
Jul 05, 2023 $OGI
Organigram Holdings
— Corp. Event Sell 268,500 — — 10
Jul 05, 2023 $OGI
Organigram Holdings
— Corp. Event Sell 187,500 — — 10
Jul 05, 2023 $OGI
Organigram Holdings
— Corp. Event Sell 55,741 — — 10
Sep 29, 2022 $OGI
Organigram Holdings
— Comp. Grant Buy 46,602 $1.23 $57K 10
Sep 29, 2022 $OGI
Organigram Holdings
— Comp. Grant Buy 46,602 $1.23 $57K 10
Jan 18, 2021 $OGI
Organigram Holdings
— Comp. Grant Buy 50,000 $2.19 $110K 10
Jan 15, 2021 $OGI
Organigram Holdings
— Comp. Grant Buy 8,895 $2.15 $19K 10
Jan 15, 2021 $OGI
Organigram Holdings
— Comp. Grant Buy 26,686 $2.15 $57K 10
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.